<DOC>
<DOCNO>
EP-0010992
</DOCNO>
<TEXT>
<DATE>
19800514
</DATE>
<IPC-CLASSIFICATIONS>
<main>C07C-172/00</main> A61K-31/045 C07J-9/00 C07C-20060101S C07B-41/00 A61K-31/07 C07C-401/00 C07C-67/00 A61K-31/59 
</IPC-CLASSIFICATIONS>
<TITLE>
process for the preparation of 1-hydroxylated vitamin d compounds.
</TITLE>
<APPLICANT>
res inst medicine chemus  <sep>research institute for medicine and chemistry inc.<sep>research institute for medicine and chemistry inc.49 amherst streetcambridge, massachusetts 02142us<sep>research institute for medicine and chemistry inc.  <sep>
</APPLICANT>
<INVENTOR>
hesse robert henry<sep>johnson graham<sep>hesse, robert henry<sep>johnson, graham<sep>hesse, robert henry49 amherst streetcambridge massachusetts 02142us<sep>johnson, graham6 golden drive eaglestone estatemilton keynes buckinghamshiregb<sep>hesse, robert henry<sep>johnson, graham<sep>hesse, robert henry49 amherst streetcambridge massachusetts 02142us<sep>johnson, graham6 golden drive eaglestone estatemilton keynes buckinghamshiregb<sep>
</INVENTOR>
<ABSTRACT>
1-hydroxy-5,6-trans vitamin d compounds are preparÂ­ ed by oxidising a 5,6-trans vitamin d compound using a  lenic ester which may be formed in situ using selenous acid  or selenium dioxide in the presence of an alcohol.  
</ABSTRACT>
</TEXT>
</DOC>
